Supportive evidence is cerebral symptoms with moderate pleocytosis and/or elevated protein, elevated transaminases, bilirubin, and lactate dehydrogenase. sCD indicates soluble interleukin-2 receptor.

*A higher cutoff of 3000 μg/L has been suggested as being more specific.²¹